We report the results of three pharmacokinetics and tolerability studies , which used a dutasteride/tamsulosin HCl ( 0.5 mg/0 .2 mg ) fixed-dose combination ( FDC ) capsules containing a small dutasteride soft gelatin capsule ( smaller than commercial Avodart ) and modified-release tamsulosin pellets that have different amounts of enteric coating .